Dispensación hospitalaria: cuestión de dinero
EL GLOBAL
EEl debate sobre la dispensación de algunos medicamentos exclusivamente desde los Servicios de Farmacia Hospitalaria, sin intervención de las oficinas de farmacia, ha cobrado actualidad tras la publicación, por la SEFH, de su informe “El valor de la Farmacia Hospitalaria”. En este se aporta básicamente dos ideas para defender la dispensación hospitalaria: en primer lugar,... Read More
El SNS actúa como las aseguradoras privadas
EL GLOBAL
En España, el derecho a la protección de la salud no está reconocido, en la Constitución, como un derecho fundamental, sino como un principio rector de la política social y económica. El Tribunal Constitucional se ha pronunciado al respecto en múltiples ocasiones. La última, al valorar el recurso interpuesto contra el Real Decreto-Ley 16/2012, en... Read More
Main features of the new Fenin Code of Ethics
New Code of Ethics for the Spanish Healthcare Technology Sector transposing the provisions of the current “Code of Ethical Business Practice” of MedTech Europe
CAPSULAS Nº 178
Background On 21 December 2016, the general assembly of Fenin approved the new Code of Ethics for the Healthcare Technology Sector in Spain, transposing the current “Code of Ethical Business Practice” of MedTech Europe, the European association of the health technology industry. The main objective of the new Code, which will come into force on... Read More
Purchase of biological medicinal products: reference to the active ingredient is valid for defining batches
Judgment No. 445/2016 of 19 October issued by the Administrative Chamber of the High Court of Justice of the Basque Country
CAPSULAS Nº 179
Whilst confusion persists concerning how to reasonably organise the purchase of biological and biosimilar medicinal products in hospitals, this judgment offers a certain amount of clarity and is worth particular note. The case in hand was initiated following a call for tenders as part of a Framework Agreement (FA) to supply epoetin alfa. Hospira appealed... Read More
Price comparison must take into account the different characteristics of shops
Judgment of the Court of Justice of the European Union of 8 February 2017 (Case C-562/15)
CAPSULAS Nº 179
Background The judgment in question corresponds to a widespread advertising campaign in France, as part of which Carrefour Hypermarchés compared the prices of 500 leading brand products in its shops and in the shops of competitors, including those belonging to ITM Alimentaire International. The campaign showed that products sold by the latter were systematically more... Read More
Waiver to the interests for late payment by signing up to the supplier payment plan may or may not be valid
In its judgment of 16 February 2017, the Court of Justice of the European Union leaves the door open for the national court to verify whether the aforementioned waiver was freely agreed to
CAPSULAS Nº 179
Between 2008 and 2013, several companies supplied goods and provided services to medical establishments forming part of the Health Service of the Autonomous Community of the Region of Murcia, which failed to pay for those goods and services. Those companies then assigned the debts at issue to IOS Finance, a factoring company that would later... Read More
Countdown for adapting to the new European personal data protection framework
The Spanish Data Protection Agency (AEPD) publishes a range of guidelines on adapting to the General Data Protection Regulation
CAPSULAS Nº 179
The General Data Protection Regulation (GDPR), Regulation (EU) 2016/679, is the new regulatory framework adopted by the European Union on the protection of personal data. Although it was published in May 2016, it will not fully come into force until May 2018. Thereafter, both Organic Law 15/1999, on Personal Data Protection and Royal Decree 1720/2007,... Read More
Transferencias de valor e impuestos, cuestión de calidad
EL GLOBAL
Lo que está sucediendo con las transferencias de valor de la industria a los profesionales sanitarios me lleva a pensar en el equilibrio entre beneficio y riesgo que siempre hay que buscar en el mundo del medicamento; y en la necesidad de no olvidar otro elemento que también es esencial en cualquier medicamento: su calidad.... Read More
Faus & Moliner at the Early Access Programmes & Compassionate Use in the EU in Düsseldorf
Francisco Aránega made a presentation about Early access possibilities in Spain
This seminar was organized by the FORUM Institut in Düsseldorf and provided a detailed overview of early access possibilities in the EU in general as a well as in Germany, the UK, Spain and France in particular. The seminar informed about the available options for, and the arising challenges of, bringing pharmaceuticals to the European... Read More
¿Un paso atrás en la morosidad del sector público?
El Global
Muchos esperábamos con cierta expectación a que este jueves día 16 se hiciera pública la sentencia del Tribunal de Justicia de la Unión Europea (TJUE). Podría haber sido un revulsivo en la lucha contra la morosidad del sector público. Pero no pudo ser, al menos de momento.¡ La morosidad pública se ha convertido en una... Read More